'For the quarter ending Dec 2023, standalone Net sales (including other operating income) of RPG Life Sciences has increased 17.69% to Rs 153.70 crore compared to quarter ended Dec 2022. Operating profit margin has jumped from 22.37% to 24.66%, leading to 29.75% rise in operating profit to Rs 37.90 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 15.14% to 16.92%.   Purchase of finished goods cost fell from 18.98% to 11.23%.   Employee cost increased from 21.15% to 22.94%.   Other expenses rose from 22.90% to 23.11%.   

Other income up 276.47% to Rs 1.92 crore.  PBIDT rose 33.98% to Rs 39.82 crore.  Provision for interest up 100% to Rs 0.14 crore.  

PBDT rose 33.83% to Rs 39.68 crore.  Provision for depreciation rose 5.88% to Rs 4.14 crore.  

Profit before tax grew 38.07% to Rs 35.54 crore.  Provision ...

• 

  (30-Jan-2025)

  Subros

  NP up 22.56%

• 

  (30-Jan-2025)

  Gabriel India

  Sales up 24.67% and NP increased 45.72%

• 

  (30-Jan-2025)

  Craftsman Automation

  NP decreased 82.32%

• 

  (30-Jan-2025)

  Ratnaveer Precision Engineering

  Net up 22% on higher sales